However, despite the purported functional link between S1P/SPHK2 and survival of multiple myeloma cells, SL analysis of blood samples from 83 multiple myeloma patients at different stages of disease and 17 healthy patients found no difference in S1P levels in multiple myeloma patients compared to healthy patients [188]. Here, SPHK2 is linked to AL amyloidosis.